POLYMYXIN B is a Intramuscular; Intrathecal; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Xellia Pharmaceuticals Aps. The primary component is Polymyxin B Sulfate.
Product ID | 45932-0030_5039c2fa-cc43-4787-933c-a9943ca381eb |
NDC | 45932-0030 |
Product Type | Human Prescription Drug |
Proprietary Name | POLYMYXIN B |
Generic Name | Polymyxin B Sulfate |
Dosage Form | Injection |
Route of Administration | INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
Marketing Start Date | 2014-01-24 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA202766 |
Labeler Name | Xellia Pharmaceuticals ApS |
Substance Name | POLYMYXIN B SULFATE |
Active Ingredient Strength | 500000 1/1 |
Pharm Classes | Polymyxin-class Antibacterial [EPC],Polymyxins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-01-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA202766 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-01-24 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
POLYMYXIN B SULFATE | 500000 1/1 |
SPL SET ID: | 132fe072-9c9a-4c56-9004-c27ee6a467ae |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9941 | Polymyxin B | Polymyxin B sulfate |
39822-0166 | Polymyxin B | Polymyxin B |
39822-0170 | Polymyxin B | Polymyxin B |
39822-0171 | Polymyxin B | Polymyxin B |
45932-0030 | POLYMYXIN B | POLYMYXIN B SULFATE |
47781-596 | Polymyxin B | polymyxin B sulfate |
51991-939 | Polymyxin B | Polymyxin B |
55150-234 | Polymyxin B | Polymyxin B |
63323-321 | POLYMYXIN B | POLYMYXIN B SULFATE |
63323-367 | POLYMYXIN B | POLYMYXIN B SULFATE |
68083-174 | POLYMYXIN B | POLYMYXIN B SULFATE |
70594-049 | Polymyxin B | Polymyxin B Sulfate |
70860-103 | Polymyxin B | polymyxin B sulfate |
70860-124 | Polymyxin B | polymyxin B sulfate |